The global Nucleic Acid-based Therapeutics market size was valued at USD 540.1 million in 2023 and is forecast to a readjusted size of USD 698 million by 2030 with a CAGR of 3.7% during review period.
Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The report includes an overview of the development of the Nucleic Acid-based Therapeutics industry chain, the market status of Hospitals (Anti-Sense And Anti-Gene, Short Inhibitory Sequences), Academic & Research Institutes (Anti-Sense And Anti-Gene, Short Inhibitory Sequences), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nucleic Acid-based Therapeutics.
Regionally, the report analyzes the Nucleic Acid-based Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nucleic Acid-based Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nucleic Acid-based Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nucleic Acid-based Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Anti-Sense And Anti-Gene, Short Inhibitory Sequences).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nucleic Acid-based Therapeutics market.
Regional Analysis: The report involves examining the Nucleic Acid-based Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nucleic Acid-based Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nucleic Acid-based Therapeutics:
Company Analysis: Report covers individual Nucleic Acid-based Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nucleic Acid-based Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Academic & Research Institutes).
Technology Analysis: Report covers specific technologies relevant to Nucleic Acid-based Therapeutics. It assesses the current state, advancements, and potential future developments in Nucleic Acid-based Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nucleic Acid-based Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nucleic Acid-based Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Anti-Sense And Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Market segment by Application
Hospitals
Academic & Research Institutes
Market segment by players, this report covers
Wave Life Sciences
Imugene
Caperna
Phylogica
Protagonist Therapeutics
Benitec Biopharma
EGEN
BioMedica
Transgene
Copernicus Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nucleic Acid-based Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nucleic Acid-based Therapeutics, with revenue, gross margin and global market share of Nucleic Acid-based Therapeutics from 2019 to 2024.
Chapter 3, the Nucleic Acid-based Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nucleic Acid-based Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nucleic Acid-based Therapeutics.
Chapter 13, to describe Nucleic Acid-based Therapeutics research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Nucleic Acid-based Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nucleic Acid-based Therapeutics by Type
1.3.1 Overview: Global Nucleic Acid-based Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Nucleic Acid-based Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Anti-Sense And Anti-Gene
1.3.4 Short Inhibitory Sequences
1.3.5 Gene Transfer Therapy
1.3.6 Nucleoside Analogs
1.3.7 Ribozymes
1.3.8 Aptamers
1.4 Global Nucleic Acid-based Therapeutics Market by Application
1.4.1 Overview: Global Nucleic Acid-based Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Academic & Research Institutes
1.5 Global Nucleic Acid-based Therapeutics Market Size & Forecast
1.6 Global Nucleic Acid-based Therapeutics Market Size and Forecast by Region
1.6.1 Global Nucleic Acid-based Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Nucleic Acid-based Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Nucleic Acid-based Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Nucleic Acid-based Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Nucleic Acid-based Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Nucleic Acid-based Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Nucleic Acid-based Therapeutics Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Wave Life Sciences
2.1.1 Wave Life Sciences Details
2.1.2 Wave Life Sciences Major Business
2.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Product and Solutions
2.1.4 Wave Life Sciences Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Wave Life Sciences Recent Developments and Future Plans
2.2 Imugene
2.2.1 Imugene Details
2.2.2 Imugene Major Business
2.2.3 Imugene Nucleic Acid-based Therapeutics Product and Solutions
2.2.4 Imugene Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Imugene Recent Developments and Future Plans
2.3 Caperna
2.3.1 Caperna Details
2.3.2 Caperna Major Business
2.3.3 Caperna Nucleic Acid-based Therapeutics Product and Solutions
2.3.4 Caperna Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Caperna Recent Developments and Future Plans
2.4 Phylogica
2.4.1 Phylogica Details
2.4.2 Phylogica Major Business
2.4.3 Phylogica Nucleic Acid-based Therapeutics Product and Solutions
2.4.4 Phylogica Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Phylogica Recent Developments and Future Plans
2.5 Protagonist Therapeutics
2.5.1 Protagonist Therapeutics Details
2.5.2 Protagonist Therapeutics Major Business
2.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Product and Solutions
2.5.4 Protagonist Therapeutics Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Protagonist Therapeutics Recent Developments and Future Plans
2.6 Benitec Biopharma
2.6.1 Benitec Biopharma Details
2.6.2 Benitec Biopharma Major Business
2.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Product and Solutions
2.6.4 Benitec Biopharma Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Benitec Biopharma Recent Developments and Future Plans
2.7 EGEN
2.7.1 EGEN Details
2.7.2 EGEN Major Business
2.7.3 EGEN Nucleic Acid-based Therapeutics Product and Solutions
2.7.4 EGEN Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 EGEN Recent Developments and Future Plans
2.8 BioMedica
2.8.1 BioMedica Details
2.8.2 BioMedica Major Business
2.8.3 BioMedica Nucleic Acid-based Therapeutics Product and Solutions
2.8.4 BioMedica Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BioMedica Recent Developments and Future Plans
2.9 Transgene
2.9.1 Transgene Details
2.9.2 Transgene Major Business
2.9.3 Transgene Nucleic Acid-based Therapeutics Product and Solutions
2.9.4 Transgene Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Transgene Recent Developments and Future Plans
2.10 Copernicus Therapeutics
2.10.1 Copernicus Therapeutics Details
2.10.2 Copernicus Therapeutics Major Business
2.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Product and Solutions
2.10.4 Copernicus Therapeutics Nucleic Acid-based Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Copernicus Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nucleic Acid-based Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Nucleic Acid-based Therapeutics by Company Revenue
3.2.2 Top 3 Nucleic Acid-based Therapeutics Players Market Share in 2023
3.2.3 Top 6 Nucleic Acid-based Therapeutics Players Market Share in 2023
3.3 Nucleic Acid-based Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Nucleic Acid-based Therapeutics Market: Region Footprint
3.3.2 Nucleic Acid-based Therapeutics Market: Company Product Type Footprint
3.3.3 Nucleic Acid-based Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Nucleic Acid-based Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Nucleic Acid-based Therapeutics Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Nucleic Acid-based Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Nucleic Acid-based Therapeutics Market Forecast by Application (2025-2030)
6 North America
6.1 North America Nucleic Acid-based Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Nucleic Acid-based Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Nucleic Acid-based Therapeutics Market Size by Country
6.3.1 North America Nucleic Acid-based Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Nucleic Acid-based Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Nucleic Acid-based Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Nucleic Acid-based Therapeutics Market Size by Country
7.3.1 Europe Nucleic Acid-based Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid-based Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Nucleic Acid-based Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Region
8.3.1 Asia-Pacific Nucleic Acid-based Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
9 South America
9.1 South America Nucleic Acid-based Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Nucleic Acid-based Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Nucleic Acid-based Therapeutics Market Size by Country
9.3.1 South America Nucleic Acid-based Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid-based Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Nucleic Acid-based Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Country
10.3.1 Middle East & Africa Nucleic Acid-based Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Nucleic Acid-based Therapeutics Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Nucleic Acid-based Therapeutics Market Drivers
11.2 Nucleic Acid-based Therapeutics Market Restraints
11.3 Nucleic Acid-based Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Nucleic Acid-based Therapeutics Industry Chain
12.2 Nucleic Acid-based Therapeutics Upstream Analysis
12.3 Nucleic Acid-based Therapeutics Midstream Analysis
12.4 Nucleic Acid-based Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Wave Life Sciences
Imugene
Caperna
Phylogica
Protagonist Therapeutics
Benitec Biopharma
EGEN
BioMedica
Transgene
Copernicus Therapeutics
听
听
*If Applicable.
